Evidence map›Paper›PMID 37543186›Full record

ArticleJournal of cardiac failure2024

Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis.

Naman S Shetty, Vibhu Parcha, Nirav Patel, Akhil Pampana, Rajat Kalra, Ambarish Pandey, Peng Li, Alanna A Morris, Sumanth D Prabhu, Garima Arora and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiac failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Naman S ShettyDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Vibhu ParchaDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Nirav PatelDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Akhil PampanaDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Rajat KalraCardiovascular Division, University of Minnesota, Minneapolis, MN.
Ambarish PandeyDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Peng LiSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL.
Alanna A MorrisDivision of Cardiology, Emory University School of Medicine, Atlanta, GA.
Sumanth D PrabhuDivision of Cardiology, Washington University in St. Louis School of Medicine, St. Louis, MO.
Garima AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Pankaj AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL; Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL. Electronic address: parora@uabmc.edu.
University of Alabama at Birmingham · USBirmingham VA Medical Center · USEmory University · USThe University of Texas Southwestern Medical Center · USUniversity of Minnesota · USWashington University in St. Louis · US

Funding

Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood PressureR01HL160982 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological StudyR01HL163081 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black IndividualsR01HL163852 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.6M
Race, Natriuretic Peptides and Physiological PerturbationsK23HL146887 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ARORA, PANKAJ · 2019 to 2023
$969k
NHLBI NIH HHS K23 HL146887NHLBI NIH HHS R01 HL160982NHLBI NIH HHS R01 HL163081NHLBI NIH HHS R01 HL163852
6 · The paper itself

Abstract

backgroundThis study compared the predictive value of the race-independent creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR

methodsThis study combined the participant-level data from ARIC (Atherosclerosis Risk in Communities) (visit 4) and MESA (Multi-Ethnic Study of Atherosclerosis) (visit 1) to calculate eGFR

resultsAmong 15,615 individuals (median age: 62 [57-68] years; 55.0% females; 23.9% Black), the median eGFR

conclusionThe eGFR

Indexed as

AtherosclerosisHeart FailureRenal Insufficiency, ChronicBiomarkersCreatinineFemaleGlomerular Filtration RateHumansMaleMiddle AgedNational Heart, Lung, and Blood Institute (U.S.)United StatesBiomarkersCreatininecreatinineCystatin Cheart failurereclassification

Identifiers

PMID37543186
PMCPMC10838360
OpenAlexW4385583051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.